Handelsavisen
prelaunch
Companies Healthcare AHG.O
AH
AHG.O NASDAQ Health Care Providers & Services

Akso Health Group

$1,32
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
-1 125,4 %
ROE
-67,8 %
Net margin
-913,4 %
Debt / equity
Beta
52w range
Volume
Day range
Prev close
$1,47
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Akso Health Group operates as a health care provider and services company, generating revenue through its disclosed customer base.

Business. Akso Health Group (AHG.O) is a health care provider and services company listed on the NASDAQ. The firm operates within the Health Care Providers & Services industry, generating revenue through service-based models. Specific details regarding operating segments, headquarters location, and geographic presence are not provided in the available data.

Classification85 %
SectorHealth Care
Industry groupHealth Care Providers & Services
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ2 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
Northern Trust Investments, Inc.
largest disclosed fund holder
Profitability
-67,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning AHG.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to AHG.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ2 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Akso Health Group (AHG.O) is a health care provider and services company listed on the NASDAQ. The firm operates within the Health Care Providers & Services industry, generating revenue through service-based models. Specific details regarding operating segments, headquarters location, and geographic presence are not provided in the available data.

    Classification85 %
    SectorHealth Care
    Industry groupHealth Care Providers & Services
    AI synthesis
    GENERATED

    (a) Akso Health Group maintains a conservative capital structure with a debt-to-equity ratio of 0.0, indicating no recorded interest-bearing debt relative to equity. The balance sheet shows total assets of $214,953,325, funded primarily by total equity of $199,119,145 and total liabilities of $15,802,189. Liquidity is supported by cash and equivalents of $176,229,874, which represents a significant portion of total assets. Operating cash flow stands at $1,177,163, while capital expenditure is minimal at $154,460, suggesting low reinvestment requirements in the current period.

    (b) Profitability metrics indicate significant operational losses, with a net income of -$134,977,369 against revenue of $14,777,798. The company reports a negative gross profit of -$281,526, implying that direct costs of revenue exceeded sales in this period. Return on equity is -0.6779 and return on assets is -0.6279, reflecting the erosion of shareholder value due to operating losses. Without cohort median data for comparison, these returns are assessed as negative relative to standard industry benchmarks for profitable health care providers.

    Key takeaways
    • The company holds a strong cash position of $176.2 million with zero debt, providing a buffer against operational losses.
    • Significant customer concentration exists, with the top four clients accounting for over 63% of revenue.
    • Operational performance is weak, with negative gross profit and substantial net losses of $135 million.
    • Dilution risk is assessed as low, with no immediate flags for share issuance.
    • Lack of historical data prevents trend analysis, but current metrics suggest a need for operational restructuring.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $1,32
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $199.2M
    Net cash
    $176.2M
    Current ratio
    Debt / equity
    ROA
    -62.8%
    ROE
    -67.8%
    Cash conversion
    -1.0%
    CapEx / revenue
    1.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships4 disclosed relationships · 1 type · extracted from filings & disclosures
    Customers4
    ANON:CUST:AHG.O:P10.1ANON:CUST:AHG.O:P10.1Customer88%Source ↗
    ANON:CUST:AHG.O:P15.6ANON:CUST:AHG.O:P15.6Customer88%Source ↗
    ANON:CUST:AHG.O:P17.7ANON:CUST:AHG.O:P17.7Customer88%Source ↗
    ANON:CUST:AHG.O:P19.9ANON:CUST:AHG.O:P19.9Customer88%Source ↗

    Supply chain

    Vendors → AHG ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSAHGAHGAkso Health Group4 entitiesANON:CUST:AHG.O:P10.1ANON:CUST:AHG.O:P15.6ANON:CUST:AHG.O:P17.7ANON:CUST:AHG.O:P19.9
    4 mentions in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-07-04

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin-1 125,4 %Bottom quartile
    Net Margin-913,4 %Bottom quartile
    ROE-67,8 %Bottom quartile
    Capex / Rev1,1 %Above median
    D/E0,00Above median
    Cash Conv-0,01Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Return On Assets
      net_income / total_assets
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    Source documents
    • Akso Health Group Market data — financials · 2026-07-26
    • reconciler_enqueue (reconciler) on AHG.O · 2026-07-26
    • Akso Health Group HA canonical relationships · 2026-07-26

    Ownership & reference

    Top holders

    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$0M

    Leadership

    • Xiaobo AnChairman of the Board, Chief Executive Officer

    Insider activity

    — missing data

    Short positioning

    38.3Kshares short+30.6% vs prior
    3.83days to cover
    4.9%short of daily vol
    1.1Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    AHG.OCanonical
    NASDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.
    Relationship graph
    AHGANON:CUSANON:CUSANON:CUSANON:CUSHealth Care Pr
    This companySectorCustomers

    Evidence & claims

    From filings & derived data
    • Cost of revenue (annual): USD 13.84MUnknown
    • Revenue (annual): USD 13.83MUnknown
    • Pre-tax income (annual): USD -20.7MUnknown
    • EPS (diluted) (annual): USD-PER-SHARES 0Unknown
    • Operating cash flow (annual): USD -12.79MUnknown
    • Net income (annual): USD -18.67MUnknown
    • Gross profit (annual): USD -11.31KUnknown
    • Total operating expenses (annual): USD 20.69MUnknown
    • Operating income (annual): USD -20.7MUnknown
    • Capex (annual): USD 1.64KUnknown
    • EPS (basic) (annual): USD-PER-SHARES 0Unknown
    • Net income (annual): USD -134.98MUnknown
    • Gross profit (annual): USD -281.53KUnknown
    • Operating income (annual): USD -166.3MUnknown
    • Revenue (annual): USD 14.78MUnknown
    • Cost of revenue (annual): USD 15.06MUnknown
    • Pre-tax income (annual): USD -166.27MUnknown
    • Operating cash flow (annual): USD 1.18MUnknown
    • Capex (annual): USD 154.46KUnknown
    • Total operating expenses (annual): USD 166.02MUnknown
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ2 2026 earnings (expected) estimated date
    2025-08-14FILINGANNUAL REPORT →
    2024-07-30FILINGANNUAL REPORT →
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage